Terms: = Head and neck cancer AND SMARCB1, Ini1, 6598, ENSG00000099956, Snr1, SNF5L1, RDT, BAF47, hSNFS, SNF5, INI1, Sfh1p, Q12824
143 results:
1. Primary Oropharyngeal SMARCA4-Deficient Carcinoma: Expanding the Diagnostic Spectrum in head and neck cancer.
Pasricha S; Goyal S; Kamboj M; Diwan H; Gairola M; Sethi JS; Gupta M; Mehta A
Head Neck Pathol; 2024 Mar; 18(1):16. PubMed ID: 38457069
[TBL] [Abstract] [Full Text] [Related]
2. Treatment for smarcb1 (INI-1) deficient sinonasal tumor: a single-institution study.
Wang T; Wang J; Tang T; Wang L; Li Y; Song X
Neoplasma; 2023 Dec; 70(6):804-810. PubMed ID: 38247337
[TBL] [Abstract] [Full Text] [Related]
3. A diagnostic algorithm for sinonasal papillary non-keratinizing squamous cell carcinoma with DEK::AFF2 fusion and mimickers.
Laforga JB; Othman BK
Rev Esp Patol; 2024; 57(1):67-70. PubMed ID: 38246714
[TBL] [Abstract] [Full Text] [Related]
4. smarcb1-Deficient Skull Base Chondrosarcoma with 12p Duplication Presenting as Somatic-Type Malignancy Arising from Metastatic Seminoma.
Argyris PP; Challa B; Satturwar S; VanKoevering KK; Wakely PE
Head Neck Pathol; 2024 Jan; 18(1):1. PubMed ID: 38236556
[TBL] [Abstract] [Full Text] [Related]
5. A unique case of epithelioid sarcoma involving the mandibular alveolar mucosa.
Ray D; Sarangi S; Ghose S; Ray JG
Oral Surg Oral Med Oral Pathol Oral Radiol; 2024 Feb; 137(2):e16-e21. PubMed ID: 38155016
[TBL] [Abstract] [Full Text] [Related]
6. The medial transorbital approach in cranioendoscopic skull base tumor resections for locally advanced tumors.
Scholfield DW; Levyn H; Tabar VS; Ganly I; Della Rocca D; Cohen MA
J Clin Neurosci; 2024 Jan; 119():198-204. PubMed ID: 38134571
[TBL] [Abstract] [Full Text] [Related]
7. smarcb1 (ini1)-deficient sinonasal carcinoma manifesting as oral lesions: A report of two cases.
Fuoco J; Huang M; Esfandiari N; MacMillan C; Ali A; Dave K; Freilich M; Magalhaes M
Head Neck; 2024 Mar; 46(3):E32-E39. PubMed ID: 38088461
[TBL] [Abstract] [Full Text] [Related]
8. Higher Rates of Inadequate Adjuvant Radiation Dose Among Older Adults with head and neck cancer.
Raab G; Babu C; Yu Y; Givi B; Wong RJ; Lee NY; Zakeri K
Laryngoscope; 2024 May; 134(5):2206-2211. PubMed ID: 37983853
[TBL] [Abstract] [Full Text] [Related]
9. head and neck ini1-deficient carcinoma without primary: a case report.
Dubray-Vautrin A; Ghanem W; Bozec L; Gonin J; Choussy O
J Med Case Rep; 2023 Nov; 17(1):479. PubMed ID: 37974295
[TBL] [Abstract] [Full Text] [Related]
10. Clinical Outcomes of Radioactive Iodine Redifferentiation Therapy in Previously Iodine Refractory Differentiated Thyroid cancers.
Toro-Tobon D; Morris JC; Hilger C; Peskey C; Durski JM; Ryder M
Thyroid; 2024 Jan; 34(1):70-81. PubMed ID: 37917101
[No Abstract] [Full Text] [Related]
11. [Clinicopathological features of olfactory carcinoma].
Zhang CC; Li H; Cheng LQ; Wu HB
Zhonghua Bing Li Xue Za Zhi; 2023 Nov; 52(11):1138-1143. PubMed ID: 37899320
[No Abstract] [Full Text] [Related]
12. Diagnostic algorithm for challenging blue cell sinonasal carcinoma.
Laforga JB; Abdullah B
Pathol Res Pract; 2023 Aug; 248():154683. PubMed ID: 37478521
[TBL] [Abstract] [Full Text] [Related]
13. [Sinonasal neoplasms: Update from the WHO 2022].
Agaimy A
Pathologie (Heidelb); 2023 Jul; 44(4):233-239. PubMed ID: 37286851
[TBL] [Abstract] [Full Text] [Related]
14. Fine needle aspiration cytopathology of pleomorphic dermal sarcoma.
Challa BS; Plaza JA; Wakely PE
Cytopathology; 2023 Sep; 34(5):472-478. PubMed ID: 37204069
[TBL] [Abstract] [Full Text] [Related]
15. smarcb1-Deficient Sinonasal Carcinoma: Case Report and Review of the Literature.
AlMadan NM; AlEssa EA; AlGhamdi DA
Am J Case Rep; 2023 May; 24():e939244. PubMed ID: 37198880
[TBL] [Abstract] [Full Text] [Related]
16. smarcb1 (INI-1) - Deficient sinonasal carcinoma: Report of two cases.
Vasudevan G; Srinivas SP; Nayal B; Jayaprakash P; Ramaswamy B
Indian J Pathol Microbiol; 2023; 66(2):352-355. PubMed ID: 37077082
[TBL] [Abstract] [Full Text] [Related]
17. Impact of radiotherapy on the morphological and compositional structure of intra-radicular dentin.
Martini GR; Bortoluzzi EA; Minamisako MC; Bordignon NCT; Rodrigues PM; Gondak R
Braz Dent J; 2023; 34(1):45-51. PubMed ID: 36888844
[TBL] [Abstract] [Full Text] [Related]
18. Impact of Clinical Factors and Treatments on smarcb1 (INI-1)-Deficient Sinonasal Carcinoma.
Contrera KJ; Shakibai N; Su SY; Gule-Monroe MK; Roberts D; Brahimaj B; Williams MD; Ferrarotto R; Phan J; Gunn B; Raza S; DeMonte F; Hanna EY
Otolaryngol Head Neck Surg; 2023 Aug; 169(2):435-440. PubMed ID: 36856048
[TBL] [Abstract] [Full Text] [Related]
19. Clinicopathological study of pseudomyogenic hemangioendothelioma.
Yang N; Huang Y; Yang P; Yan W; Zhang S; Li N; Feng Z
Diagn Pathol; 2023 Feb; 18(1):25. PubMed ID: 36803395
[TBL] [Abstract] [Full Text] [Related]
20. smarcb1 deficient sinonasal carcinoma: An emerging entity with a diagnostic challenge.
Anila KR; Ginju V; Vishnu VL; Kumar R; Jayasree K
Indian J Pathol Microbiol; 2023; 66(1):159-161. PubMed ID: 36656230
[TBL] [Abstract] [Full Text] [Related]
[Next]
